Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiangya Tongmai Formula
- Development stage
- Unknown
- Lead developer
- Xiyuan Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Jiangya Tongmai Formula is a Traditional Chinese Medicine (TCM) herbal composition developed by Xiyuan Hospital of the China Academy of Chinese Medical Sciences. It is primarily investigated for the treatment of H-type hypertension—a condition characterized by high blood pressure and elevated homocysteine levels—and associated carotid atherosclerosis. The formula is designed to exert antihypertensive effects while simultaneously addressing vascular remodeling and plaque formation. As a multi-herb preparation, it likely functions through synergistic mechanisms that modulate vascular resistance, reduce oxidative stress, and lower homocysteine concentrations, thereby mitigating the risk of cardiovascular events.
- Other names
- Jiangya Tongmai FangJiangya Tongmai GranuleJiangya Tongmai Granules
02
Targets
IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Jiangya Tongmai Formula.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangya Tongmai Formula.